Steris (STE) Change in Account Payables (2018 - 2026)
Steris' (STE) quarterly Change in Account Payables came in at $56.9 million in Q1 2026, up 38.44% year-on-year from $41.1 million in Q1 2025, and up 297.57% quarter-over-quarter from -$28.8 million in Q4 2025.
Steris (STE) Change in Account Payables (2018 - 2026) Analysis & Trends
Steris' Change in Account Payables history runs 9 years deep, the most recent figure standing at $56.9 million for Q1 2026.
- On a quarterly basis, Change in Account Payables rose 38.44% year-over-year to $56.9 million in Q1 2026; TTM through Mar 2026 was $51.1 million, a 52.08% increase from a year earlier, with the FY2026 full-year figure at $51.1 million, up 52.08% from the prior year.
- Change in Account Payables climbed to $56.9 million in Q1 2026 per STE's latest filing, from -$28.8 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $56.9 million in Q1 2026 and bottomed at -$28.8 million in Q4 2025.
- The 5-year median for Change in Account Payables is $8.8 million (2024), against an average of $8.5 million.
- Across the five-year window, Change in Account Payables tumbled 773.44% in 2023 and jumped 1550.0% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at $3.1 million in 2022, then tumbled by 773.44% to -$21.2 million in 2023, then surged by 141.56% to $8.8 million in 2024, then plunged by 427.27% to -$28.8 million in 2025, then surged by 297.57% to $56.9 million in 2026.
- Per Business Quant, the three latest STE Change in Account Payables figures stand at $56.9 million (Q1 2026), -$28.8 million (Q4 2025), and $13.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | 221.00 Mn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | - |
| 10 | Steris | 21.34 Bn | 20.90 Bn | 697.10 Mn | 56.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.90 Mn |
| Mar 31, 2026 | 56.90 Mn |
| Dec 31, 2025 | -28.80 Mn |
| Dec 31, 2025 | -28.80 Mn |
| Sep 30, 2025 | 13.20 Mn |
| Sep 30, 2025 | 13.20 Mn |
| Jun 30, 2025 | 9.80 Mn |
| Jun 30, 2025 | 9.80 Mn |
| Mar 31, 2025 | 41.10 Mn |
| Mar 31, 2025 | 41.10 Mn |
| Dec 31, 2024 | 8.80 Mn |
| Dec 31, 2024 | 8.80 Mn |
| Sep 30, 2024 | 800,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | -17.10 Mn |
| Jun 30, 2024 | -17.10 Mn |
| Mar 31, 2024 | -12.90 Mn |
| Mar 31, 2024 | -12.90 Mn |
| Dec 31, 2023 | -21.17 Mn |
| Dec 31, 2023 | -21.17 Mn |